Release Date: 7/15/25
Cleveland Clinic’s world class facultyhas designed the 29th Annual Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of relevant research and treatment strategies for Type 1 and 2 diabetes. Participation should increase practitioners’ competence and clinical performance treatment of diabetes and its complications, which should lead to better patient outcomes. Physicians, diabetes educators, nurses, nurse practitioners, pharmacists and physician assistants will all benefit from the lessons learned throughout this activity.
+ Topics:
Session 1: New Technology and Therapies
New Technology: Equity and Access
Sarah Macleish, DO
Advanced Hybrid Closed Loop Insulin Pumps in Pregnancy
Kevin Borst, DO
Preventing Type 2 Diabetes: Current Management of Pre Diabetes
Oscar Morey Vargas, MD
Nutritional Supplements in Treatment of DM 2: Focus on Berberine
Keren Zhou, MD
Oral GLP-1 Receptor and Multi-Agonist Therapies for Diabetes and Obesity
Robert Zimmerman, MD
Session 2: Diabetes Complications I
Increased Risk of Demetia in Patients with Diabetes and How to Prevent
Willy Valencia Rodrigo, MD
Effect of Intensive BP Control in Diabetes. New insights from BP ROAD
Dennis Bruemmer, MD, PhD
Approach to Post Bariatric Surgery Hypoglycemia
Lina Alkhaled, MD
GLP-1RA and GIP/GLP-1RA: Pancreatitis, Thyroid Cancer and Gastroparesis, Oh My!
Kevin Pantalone, DO
The Tortoise Wins: Slow, Sleady and Strong Glycemic Control
Ravali Veeramachaneni, MD
Session 3: Pumps and Monitoring
Use of Insulin Pumps; Innovations in the Last Year
Diana Isaacs, PharmD
Continuous Glucose Monitoring
Cecilia Lansang, MD
Session 4: Diabetes Complications II
Preserving Muscle Mass With Weight Loss With High Protein Diet
Marcio Griebeler, MD
Implications of Glucose Variability on Diabetes Complications
Adi Mehta, MD
GLP1 Analogs: Effects on Obstructive Sleep Apnea
Marwan Hamaty, MD
MASLD: Who to Screen, How to Treat, When to Refer
Yael Mauer, MD





Reviews
There are no reviews yet.